Alnylam Pharmaceuticals, Inc. (ALNY)

NASDAQ: ALNY · Real-Time Price · USD

176.97

-55.43 (-23.85%)

Oct 29, 2026, 3:19 PM EDT - Market open

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	23,680	52,535	30,350	24,021	29,238	20,282
Market Cap Growth	-62.25%	73.09%	26.35%	-17.84%	44.16%	34.32%
Enterprise Value	23,360	52,584	30,296	24,278	29,564	19,873
Last Close Price	232.40	397.65	235.31	191.41	237.65	169.58

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	9.11	167.44	-	-	-	-
Forward PE	20.11	60.03	-	-	-	-
PS Ratio	5.12	14.15	13.50	13.14	28.18	24.02
PB Ratio	22.95	66.57	452.40	-108.87	-184.79	34.48
P/TBV Ratio	7.12	66.57	452.40	-	-	34.48
P/FCF Ratio	32.97	112.89	-	572.67	-	-
P/OCF Ratio	27.65	100.24	-	230.62	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	5.00	14.16	13.48	13.28	28.50	23.54
EV/EBITDA Ratio	24.26	94.37	-	-	-	-
EV/EBIT Ratio	25.64	104.84	-	-	-	-
EV/FCF Ratio	32.21	112.99	-	578.81	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.83	3.76	40.89	-12.16	-16.51	3.72
Debt / EBITDA Ratio	2.58	4.70	-	-	-	-
Debt / FCF Ratio	3.85	6.38	-	63.96	-	-
Net Debt / Equity Ratio	-0.16	0.08	0.73	-1.10	-2.65	-0.42
Net Debt / EBITDA Ratio	-0.57	0.11	-0.41	-1.07	-0.57	0.38
Net Debt / FCF Ratio	-0.76	0.13	-1.15	5.80	-0.68	0.35
Asset Turnover	0.78	0.81	0.56	0.50	0.29	0.24
Inventory Turnover	12.52	8.46	3.86	2.85	1.57	1.74
Quick Ratio	2.27	2.51	2.61	2.86	3.17	3.79
Current Ratio	2.48	2.76	2.78	3.08	3.51	4.04
Return on Equity (ROE)	140.24%	73.28%	-	-	-526.14%	-106.31%
Return on Assets (ROA)	9.51%	6.81%	-2.74%	-4.78%	-13.65%	-12.56%
Return on Invested Capital (ROIC)	48.31%	57.33%	-	-10.01%	-50.38%	-132.10%
Return on Capital Employed (ROCE)	16.50%	14.30%	-5.80%	-9.90%	-28.30%	-24.00%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	10.97%	0.60%	-0.92%	-1.83%	-3.87%	-4.21%
FCF Yield	3.03%	0.89%	-0.14%	0.18%	-2.10%	-3.54%
Buyback Yield / Dilution	-5.48%	-5.51%	-2.20%	-2.64%	-2.73%	-3.01%

SEC Filings: 10-K · 10-Q